metabol effect isradipin versu hydrochlorothiazid diabet erratum hypertens may antihypertens drug neg effect metabol control diabet patient calcium antagonist antihypertens treatment diabet possibl influenc glucos toler insulin secret insulin action unknown effect calcium antagonist isradipin glucos toler insulin secret oral glucos toler test peripher hepat insulin action euglycem clamp type II diabet patient patient placebo isradipin week double-blind design second group diabet patient thiazid diuret hydrochlorothiazid protocol systol blood pressur isradipin hydrochlorothiazid placebo versu mm Hg versu blood glucos versu mg/dl glucos level basal glucose-stimul insulin level hydrochlorothiazid placebo unchang calcium antagonist treatment basal hepat glucos product peripher insulin resist hydrochlorothiazid placebo calcium antagonist therapi data calcium antagonist isradipin effect glucos toler insulin secret insulin action type II diabet patient use drug antihypertens treatment diabet diuret treatment metabol control reduct insulin action type II mellitu 